MEFENAMIC ACID | A090562 | MICRO LABS LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Pitney, Hardin, Kipp & Szuch - Citizen Petition FDA-1997-P-0003 · 4 docket documents The law firm Pitney, Hardin, Kipp & Szuch filed this citizen petition on April 10, 1997, requesting permission under 21 CFR 314.93 and Section 505(j)(2)(C) of the Federal Food, Drug, and Cosmetic Act to file an Abbreviated New Drug Application for Mefenamic Acid Tablets 250 mg, which would differ fr | Other | 2013-09-16 | Withdrawn | — |
Lachman Consultant Sevices, Inc.- Citizen Petition FDA-2012-P-1058 · 4 docket documents Lachman Consultant Services, Inc., on behalf of a client, filed this petition under Section 505(j)(2)(C) of the Federal Food, Drug and Cosmetic Act requesting that the FDA declare Mefenamic Acid Capsules USP, 500 mg suitable for submission in an abbreviated new drug application, with the reference l | Other | 2012-10-19 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.9590
per ea
Lowest NADAC/Unit
$0.9590
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 42571025830MEFENAMIC ACID 250 MG CAPSULE | $0.9590 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.